Pharmacists in Roslyn, New York


14 Pharmacists found in Roslyn
female pharmacist

Amanda Tolento, PHARM.D.


Pharmacist
100 Port Washington Blvd, Roslyn, NY 11576
516-562-6262    

male pharmacist

Chetak Jain, PHARMD


Pharmacist
10 Bonnie Lynn Ct, Roslyn, NY 11576
516-902-4468    

female pharmacist

Diana Khaimova


Pharmacist
21 Vine St, Roslyn, NY 11576
646-400-8342    



female pharmacist

Esther Lee


Pharmacist
20 Oakwood Cir, Roslyn, NY 11576
917-297-6731    

female pharmacist

Eunmi Cho, PHARMD, RPH


Pharmacist
14 Sterling Plz, Roslyn, NY 11576
516-314-3190    

female pharmacist

Mrs. Ladan Lilly Vahdaty-darvish, PHARMACISIT


Pharmacist
49 The Birches, Roslyn, NY 11576
516-484-4921    

female pharmacist

Dr. Megan Lam, PHARMD


Pharmacist
104 Ursula Dr, Roslyn, NY 11576
516-426-7829    

male pharmacist

Mr. Mohammed Abdur Rouf, RPH


Pharmacist
26 Pin Oak Dr, Roslyn, NY 11576
516-330-3605    

female pharmacist

Dr. Nina Yousefzadeh, PHARMD


Pharmacist - Geriatric
6 Junard Dr, Roslyn, NY 11576
516-428-4005    

male pharmacist

Mr. Rangasamy Anbalagan, RPH


Pharmacist
54 Sugar Maple Dr, Roslyn, NY 11576
516-294-9254    

female pharmacist

Sahar Ahmed Rabbat, PHARM.D


Pharmacist
18 Shrub Hollow Rd, Roslyn, NY 11576
516-637-9736    

female pharmacist

Shila Zokai-neman


Pharmacist
55 Green Dr, Roslyn, NY 11576
516-833-6980    

female pharmacist

Somtoochukwu Ojukwu, PHARMD


Pharmacist
100 Port Washington Blvd, Roslyn, NY 11576
516-562-6000    

male pharmacist

Todd Helmut Vahldieck, RPH


Pharmacist
100 Port Washington Blvd, Roslyn, NY 11576
516-562-6262    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.